Colgate-Palmolive (NYSE:CL) Given Average Rating of “Moderate Buy” by Analysts

Shares of Colgate-Palmolive (NYSE:CL) have earned a consensus rating of “Moderate Buy” from the twelve analysts that are covering the company, MarketBeat.com reports. Four analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $82.57.

A number of brokerages have commented on CL. JPMorgan Chase & Co. cut their price objective on shares of Colgate-Palmolive from $85.00 to $81.00 and set an “overweight” rating for the company in a research report on Thursday, October 12th. Citigroup lowered their price target on shares of Colgate-Palmolive from $92.00 to $85.00 and set a “buy” rating on the stock in a research note on Wednesday, October 11th. Royal Bank of Canada upped their price target on shares of Colgate-Palmolive from $79.00 to $80.00 and gave the stock a “sector perform” rating in a research note on Monday, October 30th. Sanford C. Bernstein lowered their price target on shares of Colgate-Palmolive from $82.00 to $76.00 in a research note on Thursday, October 12th. Finally, Stifel Nicolaus raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and lowered their price target for the stock from $85.00 to $81.00 in a research note on Monday, October 16th.

Insider Buying and Selling at Colgate-Palmolive

In other news, insider John W. Kooyman sold 3,000 shares of the stock in a transaction dated Friday, November 3rd. The shares were sold at an average price of $75.11, for a total transaction of $225,330.00. Following the transaction, the insider now directly owns 5,347 shares in the company, valued at approximately $401,613.17. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other news, Director Lorrie M. Norrington sold 6,329 shares of the stock in a transaction dated Thursday, November 2nd. The shares were sold at an average price of $74.56, for a total transaction of $471,890.24. Following the transaction, the director now directly owns 31,307 shares in the company, valued at approximately $2,334,249.92. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider John W. Kooyman sold 3,000 shares of the stock in a transaction dated Friday, November 3rd. The stock was sold at an average price of $75.11, for a total transaction of $225,330.00. Following the transaction, the insider now owns 5,347 shares in the company, valued at $401,613.17. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 93,153 shares of company stock worth $6,851,466. Corporate insiders own 0.34% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the business. Dimensional Fund Advisors LP grew its position in Colgate-Palmolive by 4.0% in the first quarter. Dimensional Fund Advisors LP now owns 2,444,508 shares of the company’s stock valued at $185,376,000 after acquiring an additional 94,837 shares in the last quarter. Covestor Ltd grew its position in Colgate-Palmolive by 71.9% in the first quarter. Covestor Ltd now owns 2,451 shares of the company’s stock valued at $186,000 after acquiring an additional 1,025 shares in the last quarter. Mackenzie Financial Corp grew its position in Colgate-Palmolive by 8.5% in the first quarter. Mackenzie Financial Corp now owns 1,882,813 shares of the company’s stock valued at $142,774,000 after acquiring an additional 146,936 shares in the last quarter. First Western Trust Bank acquired a new stake in Colgate-Palmolive in the first quarter valued at approximately $569,000. Finally, Wsfs Capital Management LLC acquired a new stake in Colgate-Palmolive in the first quarter valued at approximately $288,000. Hedge funds and other institutional investors own 78.36% of the company’s stock.

Colgate-Palmolive Stock Down 0.1 %

CL stock opened at $75.47 on Tuesday. The company has a market cap of $62.14 billion, a price-to-earnings ratio of 39.31, a price-to-earnings-growth ratio of 3.35 and a beta of 0.46. The company has a debt-to-equity ratio of 21.40, a current ratio of 1.16 and a quick ratio of 0.74. Colgate-Palmolive has a 12 month low of $67.62 and a 12 month high of $82.09. The company has a fifty day moving average price of $72.93 and a 200 day moving average price of $75.15.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, October 27th. The company reported $0.86 EPS for the quarter, topping analysts’ consensus estimates of $0.80 by $0.06. The company had revenue of $4.92 billion during the quarter, compared to the consensus estimate of $4.81 billion. Colgate-Palmolive had a net margin of 8.29% and a return on equity of 533.40%. Colgate-Palmolive’s quarterly revenue was up 10.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.74 EPS. Sell-side analysts expect that Colgate-Palmolive will post 3.21 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, November 15th. Shareholders of record on Monday, October 23rd were issued a $0.48 dividend. The ex-dividend date of this dividend was Friday, October 20th. This represents a $1.92 dividend on an annualized basis and a yield of 2.54%. Colgate-Palmolive’s dividend payout ratio (DPR) is 100.00%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.